CD248 and neoplasm: TEM1/endosialin was originally characterized as an endothelial cell marker, although recent studies have provided evidence for its expression in endothelial progenitor cells, mesenchymal stem cells, tumor pericytes, all of which contribute to the tumor vasculature, and a subpopulation of tumor stromal cells [8,10,17-20].